Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 Jul;58(7):2144–2148. doi: 10.1128/iai.58.7.2144-2148.1990

Comparative study of hemolytic substances produced by coagulase-negative Staphylococcus strains.

M Loyer 1, R Beaudet 1, J G Bisaillon 1
PMCID: PMC258789  PMID: 2114358

Abstract

Hemolytic substances H7, H62, and E56, produced by Staphylococcus haemolyticus 7 and 62 and S. epidermidis 56, respectively, were purified. H7 and H62 are probably similar on the basis of their isoelectric focusing profiles in 8 M urea and complete immunological identity as revealed by immunodiffusion with rabbit anti-H7 and anti-E56 sera. For E56, we observed seven bands instead of three in isoelectric focusing and only partial immunological identity with H7 and H62. However, H7 and E56 were similar with regard to the following characteristics: hemolytic spectra against different erythrocytes, kinetics of erythrocyte lysis, heat stability, and inhibition by phosphatidylcholine. E56 was not active at a temperature lower than or equal to 25 degrees C, and its activity increased more rapidly with increased temperature compared with H7. For both substances, the complexes obtained by molecular filtration on Ultrogel AcA54 and the purified peptides by reverse-phase high-pressure liquid chromatography showed some hemolytic activity. These results suggest that a particular association or the presence of a given peptide could enhance the activity.

Full text

PDF
2144

Images in this article

2145Image
on p.2145
2145Image
on p.2145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaudet R., Bisaillon J. G., Saheb S. A., Sylvestre M. Production, purification, and preliminary characterization of a gonococcal growth inhibitor produced by a coagulase-negative staphylococcus isolated from the urogenital flora. Antimicrob Agents Chemother. 1982 Aug;22(2):277–283. doi: 10.1128/aac.22.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bhakdi S., Tranum-Jensen J., Sziegoleit A. Mechanism of membrane damage by streptolysin-O. Infect Immun. 1985 Jan;47(1):52–60. doi: 10.1128/iai.47.1.52-60.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bisaillon J. G., Beaudet R., Saheb S. A., Morisset R. Interference of Neisseria gonorrhoeae growth by aerobic bacterial representatives of the urogenital flora. Rev Can Biol. 1980 Dec;39(4):201–208. [PubMed] [Google Scholar]
  4. Bisaillon J. G., Lafond L., Beaudet R., Saheb S. A., Sylvestre M. Comparison of bacteriostatic and bactericidal inhibitors of Neisseria gonorrhoeae growth produced in vitro by urogenital staphylococci. Exp Biol. 1985;43(4):231–242. [PubMed] [Google Scholar]
  5. Etienne J., Brun Y., el Solh N., Delorme V., Mouren C., Bes M., Fleurette J. Characterization of clinically significant isolates of Staphylococcus epidermidis from patients with endocarditis. J Clin Microbiol. 1988 Apr;26(4):613–617. doi: 10.1128/jcm.26.4.613-617.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fitton J. E., Dell A., Shaw W. V. The amino acid sequence of the delta haemolysin of Staphylococcus aureus. FEBS Lett. 1980 Jun 30;115(2):209–212. doi: 10.1016/0014-5793(80)81170-7. [DOI] [PubMed] [Google Scholar]
  7. Frenette M., Beaudet R., Bisaillon J. G., Portelance V. Site of action of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus. J Med Microbiol. 1988 Jul;26(3):199–204. doi: 10.1099/00222615-26-3-199. [DOI] [PubMed] [Google Scholar]
  8. Frenette M., Beaudet R., Bisaillon J. G., Sylvestre M., Portelance V. Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital flora. Infect Immun. 1984 Nov;46(2):340–345. doi: 10.1128/iai.46.2.340-345.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gemmell C. G., Roberts E. Toxins and enzymes of coagulase negative staphylococci isolated from human infections. J Hyg Epidemiol Microbiol Immunol. 1974;18(3):276–280. [PubMed] [Google Scholar]
  10. John J. F., Jr, Gramling P. K., O'Dell N. M. Species identification of coagulase-negative staphylococci from urinary tract isolates. J Clin Microbiol. 1978 Oct;8(4):435–437. doi: 10.1128/jcm.8.4.435-437.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kleck J. L., Donahue J. A. Production of thermostable hemolysin by cultures of Staphylococcus epidermidis. J Infect Dis. 1968 Jun;118(3):317–323. doi: 10.1093/infdis/118.3.317. [DOI] [PubMed] [Google Scholar]
  12. Kreger A. S., Kim K. S., Zaboretzky F., Bernheimer A. W. Purification and properties of staphylococcal delta hemolysin. Infect Immun. 1971 Mar;3(3):449–465. doi: 10.1128/iai.3.3.449-465.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Lafond L., Bisaillon J. G., Saheb S. A., Beaudet R., Sylvestre M. In vitro antigonococcal activity of urogenital coagulase-negative staphylococci. Can J Microbiol. 1981 Jan;27(1):138–141. doi: 10.1139/m81-021. [DOI] [PubMed] [Google Scholar]
  16. Scheifele D. W., Bjornson G. L. Delta toxin activity in coagulase-negative staphylococci from the bowels of neonates. J Clin Microbiol. 1988 Feb;26(2):279–282. doi: 10.1128/jcm.26.2.279-282.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Scheifele D. W., Bjornson G. L., Dyer R. A., Dimmick J. E. Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun. 1987 Sep;55(9):2268–2273. doi: 10.1128/iai.55.9.2268-2273.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Watson D. C., Yaguchi M., Bisaillon J. G., Beaudet R., Morosoli R. The amino acid sequence of a gonococcal growth inhibitor from Staphylococcus haemolyticus. Biochem J. 1988 May 15;252(1):87–93. doi: 10.1042/bj2520087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wiseman G. M. The hemolysins of Staphylococcus aureus. Bacteriol Rev. 1975 Dec;39(4):317–344. doi: 10.1128/br.39.4.317-344.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES